Concepedia

Assessment of Ethnic Differences in the Pharmacokinetics and Pharmacodynamics of Valsartan

Gangadhar Sunkara, Ching‐Ming Yeh, Monica Ligueros- Saylan, Hiroto Kawashita, Nozomu Koseki

Journal of Bioequivalence & Bioavailability · 2010 · 13 citations · 13 references

DOIFull text

Open access

Concepts

Abstract

Objective: To assess the potential ethnic differences in pharmacokinetics and pharmacodynamics of valsartan between Japanese and Caucasian subjects.

References

13

Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT<sub>1</sub>‐receptor subtype

Leoluca Criscione, Marc de Gasparo, Peter Bühlmayer et al. · British Journal of Pharmacology · 1993 · 251 citations · Full text

, , +15

INVOLVEMENT OF TRANSPORTERS IN THE HEPATIC UPTAKE AND BILIARY EXCRETION OF VALSARTAN, A SELECTIVE ANTAGONIST OF THE ANGIOTENSIN II AT1-RECEPTOR, IN HUMANS

Wakaba Yamashiro, Kazuya Maeda, Masakazu Hirouchi et al. · Drug Metabolism and Disposition · 2006 · 201 citations

, , +17

Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man

Gérard Flesch, Philipp Müller, Peter Lloyd · European Journal of Clinical Pharmacology · 1997 · 201 citations

, , +11

Effects of organic anion transporting polypeptide 1B1 haplotype on pharmacokinetics of pravastatin, valsartan, and temocapril

Kiyoshi Maeda, Ichiro Ieiri, Kiyomi Yasuda et al. · Clinical Pharmacology & Therapeutics · 2006 · 199 citations

, , +13

Valsartan: Preclinical and Clinical Profile of an Antihypertensive Angiotensin‐II Antagonist

Leoluca Criscione, William A. Bradley, Peter Bühlmayer et al. · Cardiovascular Drug Reviews · 1995 · 132 citations

, , +14